T0	Participants 53 84	arterial hypertensive patients.
T1	Participants 161 281	49 hypertensive patients (WHO I-II), divided into three parallel randomized groups, were studied over a 6 months period.
T2	Participants 1615 1674	hypertensive subjects with metabolic coronary risk factors.